The expression of serglycin across 51 human breast cancer cell lines [21] clustered into three subgroups (Luminal, Basal A and Basal B) was obtained by the Cell Lines module in the Gene Set Analysis using GOBO database (http://co.bmc.lu.se/gobo/gobo.pl). Here, SRGN is linked to breast carcinoma.